Cargando…
Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients
OBJECTIVE: Data regarding efficacy comparison of daily regimen (DR) versus every other day regimen (EODR) atorvastatin therapy is not validated by estimation of serum hydroxymethylglutaryl-CoA reductase (HMGCR) levels and HMGCR correlation with lipid indices. METHODS: In this randomized controlled t...
Autores principales: | Kumar, Manoj, Rehan, Harmeet Singh, Puri, Raman, Yadav, Madhur, Gupta, Lalit Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310732/ https://www.ncbi.nlm.nih.gov/pubmed/30595323 http://dx.doi.org/10.1016/j.ihj.2018.05.010 |
Ejemplares similares
-
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
por: Grover, Abhinav, et al.
Publicado: (2017) -
Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels
por: Grover, Abhinav, et al.
Publicado: (2020) -
The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage
por: Wong, George Kwok Chu, et al.
Publicado: (2010) -
In Silico Characterization
of Withania
coagulans Bioactive Compounds as Potential Inhibitors
of Hydroxymethylglutaryl (HMG-CoA) Reductase of Mus
musculus
por: Azmi, Muhammad Bilal, et al.
Publicado: (2023) -
Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012)